Endurant for Challenging Anatomy: Global Experience Registry
EAGLE
EVAR Treatment With the Endurant Stent Graft of Challenging Anatomy in Experienced Hands, the Real World Experience
1 other identifier
observational
150
1 country
1
Brief Summary
The Department of Vascular Surgery at Catharina Hospital Eindhoven, The Netherlands initiates the Endurant for Challenging Anatomy: Global Experience (EAGLE) Registry. The aim of this study is to collect clinical information on the performance of the Endurant Stent Graft System for endovascular repair in anatomically challenging aneurysms, and to critically assess whether the current guidelines for anatomic eligibility to endovascular treatment with this system are still applicable. This study aims at creating a database that can be pooled/ compared with the ENGAGE database. This study aims at answering two major questions:
- 1.Is the technical success rate of successful delivery and deployment of the Endurant (II) similar in anatomically challenging aneurysm?
- 2.Is the successful treatment rate comparable in anatomically challenging aneurysms, or does treatment of these aneurysms lead to more complications and reinterventions?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2012
CompletedFirst Submitted
Initial submission to the registry
February 12, 2013
CompletedFirst Posted
Study publicly available on registry
March 13, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2023
CompletedDecember 26, 2023
December 1, 2023
5.2 years
February 12, 2013
December 20, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Clinical success
Freedom from: * Increase of AAA diameter \> 5 mm (1 month measurement as baseline) * Type I\&III endoleaks * Aneurysm rupture * Conversion to surgery * Stent graft migration (\>10mm) resulting in SAE or reintervention * Stent graft occlusion
12 months
Secondary Outcomes (1)
Helath Related Quality of Life Scores
12 months
Study Arms (1)
Abdominal Aortic Aneurysm (Challenging anatomy)
Endovascular aneurysm repair
Interventions
Eligibility Criteria
Patients with abdominal aortic aneurysms (AAAs) with challenging anatomy defined by having one or more of the following measurements: * Proximal necks 5 - 10mm in combination with \< 60 degrees infrarenal AND \< 45 degrees suprarenal angulation * Proximal necks 10 - 15mm in combination with 60 degrees - 75 degrees infrarenal AND \< 60 degrees suprarenal angulation OR in combination with \< 75 degrees infrarenal AND 45 degrees - 60 degrees suprarenal angulation * Proximal necks \> 15mm in combination with 75 degrees - 90 degrees infrarenal AND \< 75 degrees suprarenal angulation OR in combination with \< 90 degrees infrarenal AND 60 degrees - 75 degrees suprarenal angulation
You may qualify if:
- Age ≥ 18 years or minimum age as required by local regulations
- Indication for elective EVAR
- Challenging AAA anatomy
- Intention to electively implant the Endurant or Endurant II Stent Graft System©
- Signed informed consent form
You may not qualify if:
- Subjects with intolerance to contrast media
- Chimneys or fenestrated device procedures
- High probability of non-adherence to physician's follow-up requirements
- Current participation in a concurrent trial that may confound study results
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Catharina Ziekenhuis
Eindhoven, North Brabant, 5602 ZA, Netherlands
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
February 12, 2013
First Posted
March 13, 2013
Study Start
November 1, 2012
Primary Completion
January 1, 2018
Study Completion
May 1, 2023
Last Updated
December 26, 2023
Record last verified: 2023-12